ERNESTINA ATKINS: Open Payments
NPI 1801371703 · NORTH BEACH, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 34 payments from 12 companies in 2025. Trend: 2023 $297 · 2024 $661 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $242 |
| Corcept Therapeutics | 3 | $89 |
| Lilly USA, LLC | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 4 | $60 |
| PFIZER INC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| Organon LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: VRAYLAR, Korlym, MOUNJARO, VOQUEZNA, NURTEC ODT, Cologuard Collection Kit, NEXPLANON, UBRELVY.
Industry payments across MD — which companies pay providers there.
